Question 1

Do peptides actually work, or are they just a biohacking trend?

Accepted Answer

Both are true, depending on the peptide. Some are approved drugs with large human trials and measurable effects. Others are sold on trend energy and only have cell or rodent data. The useful question is not 'do peptides work' but 'what human evidence exists for this peptide, for this goal'.

Question 2

What does it mean for a peptide to be FDA-approved or not?

Accepted Answer

An approval always covers a specific product, for a specific indication, population and label: the regulator reviewed clinical trials and manufacturing. Not being approved does not prove something is dangerous, but it does not establish safety or effectiveness either — nobody verified it. Compounded preparations are not FDA-approved either.

Question 3

What is the difference between a compounded product and an FDA-approved one?

Accepted Answer

An approved medicine has gone through regulatory review of efficacy, safety and manufacturing, and every batch is made under that approval. A compounded product is prepared by a pharmacy for a specific need and does not go through that review: neither the finished product nor its batches are FDA-approved.

Question 4

When I read that a peptide is 'in phase 2', what does that actually mean?

Accepted Answer

Each phase answers a different question. Phase 1: is it tolerable and what does the body do with it? Phase 2: does it seem to do something, and at what safety margin? Phase 3: does it really work against a comparator, in many people? Being in phase 2 means the important question has not been answered yet.

Question 5

Why does it matter so much whether a study had a placebo and was double-blind?

Accepted Answer

Without a comparison group you cannot tell whether improvement came from the compound or from time, rest, placebo response or expectation. A control group gives a reference point, randomisation stops the groups forming in biased ways, and blinding keeps participant and assessor expectations from bending the measurement.

Question 6

If a peptide worked in rats, why isn't that enough to say it works in people?

Accepted Answer

Animal studies exist to generate hypotheses and flag toxicity signals, not to claim something works in people. Species differences, the amounts used, artificial disease models and effect sizes mean a majority of promising preclinical results are not reproduced in human trials.

Question 7

When a headline says 'cuts risk by 30%', what does that number actually mean?

Accepted Answer

A 30% figure is usually a relative reduction: it compares two groups with each other. If risk went from 2% to 1.4%, that is a 30% relative reduction and a 0.6 percentage-point absolute one. Both numbers are true, but the absolute one tells you how much actually changes. A relative figure alone is missing context.

Question 8

What does 'statistically significant' mean, and does it mean the result matters?

Accepted Answer

Significant means the result would be unlikely if there were no real difference at all; it is a statement about chance, not about size. A large study can detect minute differences and call them significant. Whether it matters depends on the effect size, what was measured, and in whom.

Question 9

What is an 'endpoint', and what does it mean when it is a surrogate?

Accepted Answer

The endpoint is the result a study measures to decide whether something worked. It can be clinical — something the person experiences — or surrogate: a lab or imaging marker used as a stand-in because it is faster to measure. A marker improving does not guarantee the outcome that matters improves.

Question 10

What is the difference between an observational study and a randomised trial?

Accepted Answer

An observational study looks at what people already do; a randomised trial assigns at random who gets what. Randomisation also spreads out the differences nobody measured, which is why it supports stronger causal claims. Observational work is still useful for spotting signals and studying large, real-world populations.

Question 11

If a study is 'peer reviewed', does that mean it is correct?

Accepted Answer

Peer review is an editorial filter: other researchers judge whether the method, analysis and conclusions are reasonable before publication. It does not verify the raw data, does not repeat the experiment, and does not guarantee the result is true. It is a minimum quality signal, not a stamp of truth.

Question 12

How do you read a confidence interval in a study?

Accepted Answer

A confidence interval is the range of values compatible with the observed data. The narrower it is, the more precise the estimate. A very wide interval means the study is compatible with quite different results. An interval that includes 'no effect' means the data cannot rule out no difference at all.

Question 13

Why can a study with few participants mislead you?

Accepted Answer

With few participants, chance weighs heavily: the result may exaggerate a real effect or miss one that exists. That is low statistical power. Small studies are useful for exploring and generating hypotheses, but not for treating an effect as established — especially when the result looks striking.

Question 14

What is the difference between a preprint and a peer-reviewed paper?

Accepted Answer

A preprint is a manuscript the authors post before external review. It shares results quickly, but nobody outside the team has yet checked the methods or the analysis. A peer-reviewed paper has passed that filter, which does not guarantee it is correct — only that it was examined.

Question 15

Why does a systematic review carry more weight than a single study?

Accepted Answer

A systematic review searches for every study on a question using a declared method and appraises them. A meta-analysis goes further and combines their results into one estimate. These usually give a steadier picture than a single study, but they are only as good as the studies they include.

Question 16

What is the difference between an 'adverse event' and a 'side effect'?

Accepted Answer

An adverse event is any health problem occurring during a study or after using a product, whether or not it was caused by it. A side effect implies the product is held responsible. That is why pharmacovigilance reports talk about events: they record what happened, not what was proven.

Question 17

On a drug label, what is the difference between a contraindication and a warning?

Accepted Answer

A contraindication describes situations where risk outweighs any possible benefit and the product should not be used. A warning or precaution flags risks that require monitoring or judgement, without ruling use out. They are separate label sections and they do not mean the same thing.

Safety and evidence

Affiliate Partners

Peptira

Join the Péptidos Fácil community